Skip to content

A confirmation study for improving effects of probiotics and synbiotics on intestinal environment in healthy adults.

A confirmation study for improving effects of probiotics and synbiotics on intestinal environment in healthy adults. - A confirmation study for improving effects of probiotics and synbiotics on intestinal environment.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029253
Enrollment
60
Registered
2019-04-01
Start date
2017-09-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects with a tendency for constipation

Interventions

Sponsors

KSO Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects whose defecation frequency is no fewer than 2, nor more than 5. 2. Subjects who usually have three meals a day.

Exclusion criteria

Exclusion criteria: 1. Subjects who regularly use intestinal drugs and laxatives (including strong laxatives). 2. Subjects who regularly intake healthy food to relieve constipation. 3. Subjects who use medicine such as antibiotics that affect digestion and absorption. 4. Subjects who can't stop intake food containing viable bacteria such as Lactic acid bacteria, Bifidobacteria, Natto bacteria and/or enhanced with oligosaccharide, dietary fiber and/or the health food to relieve constipation (including Food for Specified Health Uses (FOSHU)) and/or containing a large amount of sugar alcohol during this study. 5. Subjects who have allergic to food. 6. Subjects who have serious diseases requiring an urgent treatment, or who accept severe complication. 7. Subjects who has a medical history of diseases or surgeries affecting digestion, absorption and bowel movement. 8. Subjects are judged unsuitable for this study based on subject questionnaire. 9. Subjects who is pregnant or willing to be pregnant or breast-feeding during this study 10. Subjects who has a current or history of drug dependence and/or alcoholism. 11. Subjects who are participated in other clinical trials that intake/apply any of food, drug, and cosmetics, or willing to be that 12. Subjects who are judged unsuitable for this study by principal investigator

Design outcomes

Primary

MeasureTime frame
fecal bifidobacteria

Secondary

MeasureTime frame
defecation days, defecation frequency

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Co., Ltd Sales Corporation

yoshikawa@kso.co.jp+81-3-3542-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026